
|Videos|May 26, 2016
- Gastrointestinal Cancers: mCRC (Issue 8)
Novel Targets in Gastric Cancer
Author(s)Manish Shah, MD
Manish A. Shah, MD, medical oncology, NewYork-Presbyterian/Weill Cornell discusses novel targets in gastric cancer outside of HER2.
Advertisement
Articles in this issue
over 9 years ago
Pessimism Surrounds VEGF Inhibitors in Advanced Gastric Cancerover 9 years ago
The Link Between Helicobacter Pylori and Gastric Cancerover 9 years ago
Unmet Needs and Future Treatment Approaches in Gastric CancerAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5



















